Oculis Holding AG

NASDAQ (USD): Oculis Holding AG (OCS)

Last Price

11.68

Today's Change

-0.01 (0.08%)

Day's Change

11.52 - 11.70

Trading Volume

5,046

Overview

Market Cap

487 Million

Shares Outstanding

41 Million

Avg Volume

26,329

Avg Price (50 Days)

11.78

Avg Price (200 Days)

11.44

PE Ratio

64.89

EPS

0.18

Earnings Announcement

14-Aug-2024

Previous Close

11.69

Open

11.57

Day's Range

11.529 - 11.7

Year Range

9.05 - 14.5

Trading Volume

5,046

Price Change Highlight

1 Day Change

-0.09%

5 Day Change

-0.34%

1 Month Change

-0.17%

3 Month Change

-2.42%

6 Month Change

5.70%

Ytd Change

5.70%

1 Year Change

-3.55%

3 Year Change

21.04%

5 Year Change

20.41%

10 Year Change

20.41%

Max Change

20.41%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Oculis Holding AG, a clinical-stage biopharmaceutical company, develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. The company's lead candidate is OCS-01, a topical dexamethasone formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for keratoconjunctivitis sicca, or dry eye disease; and OCS-05, a novel neuroprotective agent for acute optic neuritis and other neuro-ophtha disorders, such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company is based in Zug, Switzerland.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment